Učitavanje...
Indian pharmaceutical patent prosecution: The changing role of Section 3(d)
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of “secondary” pharmaceutical patents, i.e. patents on new forms of existing molecules and drugs. Previous research sug...
Spremljeno u:
| Izdano u: | PLoS One |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880378/ https://ncbi.nlm.nih.gov/pubmed/29608604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194714 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|